Terms: = Uterine cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Treatment
3 results:
1. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract] [Full Text] [Related]
2. KLF2 transcription suppresses endometrial cancer cell proliferation, invasion, and migration through the inhibition of npm1.
Cheng X; Shen C; Liao Z
J Obstet Gynaecol; 2023 Dec; 43(2):2238827. PubMed ID: 37610103
[TBL] [Abstract] [Full Text] [Related]
3. Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer.
Sarduy MR; García I; Coca MA; Perera A; Torres LA; Valenzuela CM; Baladrón I; Solares M; Reyes V; Hernández I; Perera Y; Martínez YM; Molina L; González YM; Ancízar JA; Prats A; González L; Casacó CA; Acevedo BE; López-Saura PA; Alonso DF; Gómez R; Perea-Rodríguez SE;
Br J Cancer; 2015 May; 112(10):1636-43. PubMed ID: 25880012
[TBL] [Abstract] [Full Text] [Related]
